Denteric is developing therapies to treat Porphyromonas gingivalis related diseases. Our initial focus is on severe periodontal disease.
Our vaccine therapy aims to generate antibodies that neutralise the proteolytic toxins of the bacteria that cause periodontal disease and inflammation. We are currently in phase I clinical trials.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 31 Queen St, Melbourne,victoria 3000,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.denteric.com
- Keywords
- built on their research.
- HQ
- Melbourne, Victoria
Denteric Pty Ltd Questions
Denteric Pty Ltd's website is http://www.denteric.com
Denteric Pty Ltd's LinkedIn profile is https://au.linkedin.com/company/denteric-pty-ltd
Denteric Pty Ltd has
8 employees.
View email and phone details for 8
employees at Denteric Pty Ltd.
Denteric Pty Ltd's industry is
Biotechnology Research
Denteric Pty Ltd's top competitors are
Proxima Bio,
Certa Therapeutics,
Currus Biologics Pty Ltd,
Jumar Bioincubator,
Cincera Therapeutics Pty Ltd,
Alkira Bio,
Rage Biotech,
Aravax,
Ena Respiratory,
Inosi Therapeutics Pty Ltd.
Denteric Pty Ltd's categories are Biotechnology Research
Denteric Pty Ltd's founding year is 2019
